Your browser doesn't support javascript.
loading
Efficacy of first-line immune checkpoint inhibitors in patients with advanced NSCLC with KRAS, MET, FGFR, RET, BRAF, and HER2 alterations.
Uehara, Yuji; Watanabe, Kageaki; Hakozaki, Taiki; Yomota, Makiko; Hosomi, Yukio.
Afiliação
  • Uehara Y; Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
  • Watanabe K; Department of Precision Cancer Medicine, Center for Innovative Cancer Treatment, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.
  • Hakozaki T; Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
  • Yomota M; Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
  • Hosomi Y; Department of Life Science and Medical Bioscience, Waseda University, Shinjuku, Tokyo, Japan.
Thorac Cancer ; 13(11): 1703-1711, 2022 06.
Article em En | MEDLINE | ID: mdl-35491960
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Thorac Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Thorac Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão